-
1
-
-
70349756868
-
Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy
-
Murphy BA, Beaumont JL, Isitt J, Garden AS, Gwede CK, Trotti AM, Meredith RF, Epstein JB, Le Q-T, Brizel DM. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. J Pain Symptom Manage. 2009;38:522-32.
-
(2009)
J Pain Symptom Manage
, vol.38
, pp. 522-532
-
-
Murphy, B.A.1
Beaumont, J.L.2
Isitt, J.3
Garden, A.S.4
Gwede, C.K.5
Trotti, A.M.6
Meredith, R.F.7
Epstein, J.B.8
Le, Q.-T.9
Brizel, D.M.10
-
2
-
-
1942469964
-
The pathobiology of mucositis
-
Sonis ST. The pathobiology of mucositis. Nat Rev Cancer. 2004;4:277-84.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 277-284
-
-
Sonis, S.T.1
-
3
-
-
0038399940
-
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
-
Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66:253-62.
-
(2003)
Radiother Oncol
, vol.66
, pp. 253-262
-
-
Trotti, A.1
Bellm, L.A.2
Epstein, J.B.3
Frame, D.4
Fuchs, H.J.5
Gwede, C.K.6
Komaroff, E.7
Nalysnyk, L.8
Zilberberg, M.D.9
-
4
-
-
84863230356
-
5-Fluorouracil induced intestinal mucositis via nuclear factor-ΚB activation by transcriptomic analysis and in vivo bioluminescence imaging
-
Chang C-T, Ho T-Y, Lin H, Liang J-A, Huang H-C, Li C-C, Lo H-Y, Wu S-L, Huang Y-F, Hsiang C-Y. 5-Fluorouracil induced intestinal mucositis via nuclear factor-ΚB activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS ONE. 2012;7:e31808.
-
(2012)
PLoS ONE
, vol.7
-
-
Chang, C.-T.1
Ho, T.-Y.2
Lin, H.3
Liang, J.-A.4
Huang, H.-C.5
Li, C.-C.6
Lo, H.-Y.7
Wu, S.-L.8
Huang, Y.-F.9
Hsiang, C.-Y.10
-
5
-
-
0038387494
-
5-Fluorouracil: mechanisms of action and clinical strategies
-
Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330-8.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 330-338
-
-
Longley, D.B.1
Harkin, D.P.2
Johnston, P.G.3
-
6
-
-
0025611018
-
Metabolism and mechanism of action of 5-fluorouracil
-
Parker WB, Cheng YC. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther. 1990;48:381-95.
-
(1990)
Pharmacol Ther
, vol.48
, pp. 381-395
-
-
Parker, W.B.1
Cheng, Y.C.2
-
7
-
-
84869874841
-
Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4
-
Soares PMG, Mota JMSC, Souza EP, Justino PFC, Franco AX, Cunha FQ, Ribeiro RA, Souza MHLP. Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4. Cytokine. 2013;61:46-9.
-
(2013)
Cytokine
, vol.61
, pp. 46-49
-
-
Soares, P.M.G.1
Mota, J.M.S.C.2
Souza, E.P.3
Justino, P.F.C.4
Franco, A.X.5
Cunha, F.Q.6
Ribeiro, R.A.7
Souza, M.H.L.P.8
-
8
-
-
84899985789
-
Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice
-
Maioli TU, de Melo Silva B, Dias MN, Paiva NC, Cardoso VN, Fernandes SO, Carneiro CM, dos Santos Martins F, de Vasconcelos Generoso S. Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice. J Negat Results Biomed. 2014;13:6.
-
(2014)
J Negat Results Biomed
, vol.13
, pp. 6
-
-
Maioli, T.U.1
Melo Silva, B.2
Dias, M.N.3
Paiva, N.C.4
Cardoso, V.N.5
Fernandes, S.O.6
Carneiro, C.M.7
Santos Martins, F.8
Vasconcelos Generoso, S.9
-
9
-
-
84931071992
-
Dietary supplementation with omega-3 fatty acid attenuates 5-fluorouracil induced mucositis in mice
-
de Vasconcelos Generoso S, Rodrigues NM, Trindade LM, Paiva NC, Cardoso VN, Carneiro CM, de Matos Ferreira AV, Faria AMC, Maioli TU. Dietary supplementation with omega-3 fatty acid attenuates 5-fluorouracil induced mucositis in mice. Lipids Health. 2015;14:1.
-
(2015)
Lipids Health.
, vol.14
, pp. 1
-
-
Vasconcelos Generoso, S.1
Rodrigues, N.M.2
Trindade, L.M.3
Paiva, N.C.4
Cardoso, V.N.5
Carneiro, C.M.6
Matos Ferreira, A.V.7
Faria, A.M.C.8
Maioli, T.U.9
-
10
-
-
84954450788
-
Vasconcelos Generoso S, Cardoso VN, Alvarez-Leite JI, Correia MITD. Pretreatment with l-citrulline positively affects the mucosal architecture and permeability of the small intestine in a murine mucositis model
-
Antunes MM, Leocádio PCL, Teixeira LG, Leonel AJ, Cara DC, Menezes GB, de Vasconcelos Generoso S, Cardoso VN, Alvarez-Leite JI, Correia MITD. Pretreatment with l-citrulline positively affects the mucosal architecture and permeability of the small intestine in a murine mucositis model. JPEN J Parenter Enteral Nutr. 2016;40(2):279-86.
-
(2016)
JPEN J Parenter Enteral Nutr.
, vol.40
, Issue.2
, pp. 279-286
-
-
Antunes, M.M.1
Leocádio, P.C.L.2
Teixeira, L.G.3
Leonel, A.J.4
Cara, D.C.5
Menezes, G.B.6
Vasconcelos Generoso, S.7
Cardoso, V.N.8
Alvarez-Leite, J.I.9
Correia, M.I.T.D.10
-
11
-
-
84926518872
-
l-Arginine pretreatment reduces intestinal mucositis as induced by 5-FU in mice
-
Leocádio PCL, Antunes MM, Teixeira LG, Leonel AJ, Alvarez-Leite JI, Machado DCC, Generoso SV, Cardoso VN, Correia MITD. l-Arginine pretreatment reduces intestinal mucositis as induced by 5-FU in mice. Nutr Cancer. 2015;67:486-93.
-
(2015)
Nutr Cancer
, vol.67
, pp. 486-493
-
-
Leocádio, P.C.L.1
Antunes, M.M.2
Teixeira, L.G.3
Leonel, A.J.4
Alvarez-Leite, J.I.5
Machado, D.C.C.6
Generoso, S.V.7
Cardoso, V.N.8
Correia, M.I.T.D.9
-
12
-
-
70449525211
-
Mucositis: the impact, biology and therapeutic opportunities of oral mucositis
-
Sonis ST. Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol. 2009;45:1015-20.
-
(2009)
Oral Oncol
, vol.45
, pp. 1015-1020
-
-
Sonis, S.T.1
-
13
-
-
0032766953
-
Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review
-
Plevová P. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncol. 1999;35:453-70.
-
(1999)
Oral Oncol
, vol.35
, pp. 453-470
-
-
Plevová, P.1
-
14
-
-
33745794489
-
Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats
-
Tooley KL, Howarth GS, Lymn KA, Lawrence A, Butler RN. Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biol Ther. 2006;5:593-600.
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 593-600
-
-
Tooley, K.L.1
Howarth, G.S.2
Lymn, K.A.3
Lawrence, A.4
Butler, R.N.5
-
15
-
-
42549126844
-
VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss
-
Bowen JM, Stringer AM, Gibson RJ, Yeoh ASJ, Hannam S, Keefe DMK. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther. 2007;6:1449-54.
-
(2007)
Cancer Biol Ther
, vol.6
, pp. 1449-1454
-
-
Bowen, J.M.1
Stringer, A.M.2
Gibson, R.J.3
Yeoh, A.S.J.4
Hannam, S.5
Keefe, D.M.K.6
-
16
-
-
56249108048
-
Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats
-
Smith CL, Geier MS, Yazbeck R, Torres DM, Butler RN, Howarth GS. Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutr Cancer. 2008;60:757-67.
-
(2008)
Nutr Cancer
, vol.60
, pp. 757-767
-
-
Smith, C.L.1
Geier, M.S.2
Yazbeck, R.3
Torres, D.M.4
Butler, R.N.5
Howarth, G.S.6
-
17
-
-
44449112574
-
Yoghurts containing probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats
-
Southcott E, Tooley KL, Howarth GS, Davidson GP, Butler RN. Yoghurts containing probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats. Dig Dis Sci. 2008;53:1837-41.
-
(2008)
Dig Dis Sci
, vol.53
, pp. 1837-1841
-
-
Southcott, E.1
Tooley, K.L.2
Howarth, G.S.3
Davidson, G.P.4
Butler, R.N.5
-
18
-
-
79953331208
-
Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats
-
Prisciandaro LD, Geier MS, Butler RN, Cummins AG, Howarth GS. Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats. Cancer Biol Ther. 2011;11:671-7.
-
(2011)
Cancer Biol Ther
, vol.11
, pp. 671-677
-
-
Prisciandaro, L.D.1
Geier, M.S.2
Butler, R.N.3
Cummins, A.G.4
Howarth, G.S.5
-
19
-
-
0010369584
-
Guidelines for the evaluation of probiotics in food: joint FAO/WHO Working Group meeting
-
London, 30 April-1 May
-
WHO. Guidelines for the evaluation of probiotics in food: joint FAO/WHO Working Group meeting, London, 30 April-1 May; 2002.
-
(2002)
-
-
-
20
-
-
84905916848
-
Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis
-
Zurita-Turk M, del Carmen S, Santos AC, Pereira VB, Cara DC, Leclercq SY, dM de LeBlanc A, Azevedo V, Chatel J-M, LeBlanc JG. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis. BMC Biotechnol. 2014;14:73.
-
(2014)
BMC Biotechnol.
, vol.14
, pp. 73
-
-
Zurita-Turk, M.1
Carmen, S.2
Santos, A.C.3
Pereira, V.B.4
Cara, D.C.5
Leclercq, S.Y.6
dM de LeBlanc, A.7
Azevedo, V.8
Chatel, J.-M.9
LeBlanc, J.G.10
-
21
-
-
84916601452
-
Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model
-
del Carmen S, Martín Rosique R, Saraiva T, Zurita-Turk M, Miyoshi A, Azevedo V, de Moreno de LeBlanc A, Langella P, Bermúdez-Humarán LG, LeBlanc JG. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model. J Clin Gastroenterol. 2014;48(Suppl 1):S12-7.
-
(2014)
J Clin Gastroenterol
, vol.48
, pp. S12-S17
-
-
Carmen, S.1
Martín Rosique, R.2
Saraiva, T.3
Zurita-Turk, M.4
Miyoshi, A.5
Azevedo, V.6
de Moreno de LeBlanc, A.7
Langella, P.8
Bermúdez-Humarán, L.G.9
LeBlanc, J.G.10
-
22
-
-
84879147444
-
Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update
-
LeBlanc JG, Aubry C, Cortes-Perez NG, de Moreno de LeBlanc A, Vergnolle N, Langella P, Azevedo V, Chatel J-M, Miyoshi A, Bermúdez-Humarán LG. Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update. FEMS Microbiol Lett. 2013;344:1-9.
-
(2013)
FEMS Microbiol Lett
, vol.344
, pp. 1-9
-
-
LeBlanc, J.G.1
Aubry, C.2
Cortes-Perez, N.G.3
Moreno de LeBlanc, A.4
Vergnolle, N.5
Langella, P.6
Azevedo, V.7
Chatel, J.-M.8
Miyoshi, A.9
Bermúdez-Humarán, L.G.10
-
23
-
-
84929620686
-
Milk fermented with a 15-lipoxygenase-1-producing Lactococcus lactis alleviates symptoms of colitis in a murine model
-
Saraiva TDL, Morais K, Pereira VB, de Azevedo M, Rocha CS, Prosperi CC, Gomes-Santos AC, Bermudez-Humaran L, Faria AMC, Blottiere HM, et al. Milk fermented with a 15-lipoxygenase-1-producing Lactococcus lactis alleviates symptoms of colitis in a murine model. Curr Pharm Biotechnol. 2015;16:424-9.
-
(2015)
Curr Pharm Biotechnol
, vol.16
, pp. 424-429
-
-
Saraiva, T.D.L.1
Morais, K.2
Pereira, V.B.3
Azevedo, M.4
Rocha, C.S.5
Prosperi, C.C.6
Gomes-Santos, A.C.7
Bermudez-Humaran, L.8
Faria, A.M.C.9
Blottiere, H.M.10
-
24
-
-
33744933432
-
A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease
-
Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon J-P, van Deventer SJH, Neirynck S, Peppelenbosch MP, Steidler L. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol. 2006;4:754-9.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 754-759
-
-
Braat, H.1
Rottiers, P.2
Hommes, D.W.3
Huyghebaert, N.4
Remaut, E.5
Remon, J.-P.6
Deventer, S.J.H.7
Neirynck, S.8
Peppelenbosch, M.P.9
Steidler, L.10
-
25
-
-
77953359952
-
AG013, a mouth rinse formulation of Lactococcus lactis secreting human trefoil factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis
-
Caluwaerts S, Vandenbroucke K, Steidler L, Neirynck S, Vanhoenacker P, Corveleyn S, Watkins B, Sonis S, Coulie B, Rottiers P. AG013, a mouth rinse formulation of Lactococcus lactis secreting human trefoil factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol. 2010;46:564-70.
-
(2010)
Oral Oncol
, vol.46
, pp. 564-570
-
-
Caluwaerts, S.1
Vandenbroucke, K.2
Steidler, L.3
Neirynck, S.4
Vanhoenacker, P.5
Corveleyn, S.6
Watkins, B.7
Sonis, S.8
Coulie, B.9
Rottiers, P.10
-
26
-
-
84889883370
-
Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy
-
Limaye SA, Haddad RI, Cilli F, Sonis ST, Colevas AD, Brennan MT, Hu KS, Murphy BA. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer. 2013;2013(119):4268-76.
-
(2013)
Cancer
, vol.2013
, Issue.119
, pp. 4268-4276
-
-
Limaye, S.A.1
Haddad, R.I.2
Cilli, F.3
Sonis, S.T.4
Colevas, A.D.5
Brennan, M.T.6
Hu, K.S.7
Murphy, B.A.8
-
27
-
-
84862661260
-
Protective effects of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis
-
Wong CCM, Zhang L, Li ZJ, Wu WKK, Ren SX, Chen YC, Ng TB, Cho CH. Protective effects of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis. J Gastroenterol Hepatol. 2012;27:1205-12.
-
(2012)
J Gastroenterol Hepatol
, vol.27
, pp. 1205-1212
-
-
Wong, C.C.M.1
Zhang, L.2
Li, Z.J.3
Wu, W.K.K.4
Ren, S.X.5
Chen, Y.C.6
Ng, T.B.7
Cho, C.H.8
-
28
-
-
84867872224
-
Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins
-
Seo E, Weibel S, Wehkamp J, Oelschlaeger TA. Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins. Int J Med Microbiol. 1917;2012(302):276-87.
-
(1917)
Int J Med Microbiol
, vol.2012
, Issue.302
, pp. 276-287
-
-
Seo, E.1
Weibel, S.2
Wehkamp, J.3
Oelschlaeger, T.A.4
-
29
-
-
33748039462
-
Symbiotic bacteria direct expression of an intestinal bactericidal lectin
-
Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 2006;313:1126-30.
-
(2006)
Science.
, vol.313
, pp. 1126-1130
-
-
Cash, H.L.1
Whitham, C.V.2
Behrendt, C.L.3
Hooper, L.V.4
-
30
-
-
66549085349
-
Proteolytic activation of human pancreatitis-associated protein is required for peptidoglycan binding and bacterial aggregation
-
Medveczky P, Szmola R, Sahin-Tóth M. Proteolytic activation of human pancreatitis-associated protein is required for peptidoglycan binding and bacterial aggregation. Biochem J. 2009;420:335-44.
-
(2009)
Biochem J.
, vol.420
, pp. 335-344
-
-
Medveczky, P.1
Szmola, R.2
Sahin-Tóth, M.3
-
31
-
-
64149129422
-
Regulation of C-type lectin antimicrobial activity by a flexible N-terminal prosegment
-
Mukherjee S, Partch CL, Lehotzky RE, Whitham CV, Chu H, Bevins CL, Gardner KH, Hooper LV. Regulation of C-type lectin antimicrobial activity by a flexible N-terminal prosegment. J Biol Chem. 2009;284:4881-8.
-
(2009)
J Biol Chem.
, vol.284
, pp. 4881-4888
-
-
Mukherjee, S.1
Partch, C.L.2
Lehotzky, R.E.3
Whitham, C.V.4
Chu, H.5
Bevins, C.L.6
Gardner, K.H.7
Hooper, L.V.8
-
32
-
-
80054122238
-
The antibacterial lectin RegIII promotes the spatial segregation of microbiota and host in the intestine
-
Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, Ley R, Wakeland EK, Hooper LV. The antibacterial lectin RegIII promotes the spatial segregation of microbiota and host in the intestine. Science. 2011;334:255-8.
-
(2011)
Science.
, vol.334
, pp. 255-258
-
-
Vaishnava, S.1
Yamamoto, M.2
Severson, K.M.3
Ruhn, K.A.4
Yu, X.5
Koren, O.6
Ley, R.7
Wakeland, E.K.8
Hooper, L.V.9
-
33
-
-
84892373963
-
Antibacterial membrane attack by a pore-forming intestinal C-type lectin
-
Mukherjee S, Zheng H, Derebe MG, Callenberg KM, Partch CL, Rollins D, Propheter DC, Rizo J, Grabe M, Jiang QX. Antibacterial membrane attack by a pore-forming intestinal C-type lectin. Nature. 2014;505:103-7.
-
(2014)
Nature.
, vol.505
, pp. 103-107
-
-
Mukherjee, S.1
Zheng, H.2
Derebe, M.G.3
Callenberg, K.M.4
Partch, C.L.5
Rollins, D.6
Propheter, D.C.7
Rizo, J.8
Grabe, M.9
Jiang, Q.X.10
-
34
-
-
85013012748
-
Manuscript in preparation
-
Breyner et al. Manuscript in preparation; 2016.
-
(2016)
-
-
Breyner1
-
35
-
-
0029757175
-
Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin
-
de Ruyter PG, Kuipers OP, de Vos WM. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol. 1996;62:3662-7.
-
(1996)
Appl Environ Microbiol.
, vol.62
, pp. 3662-3667
-
-
Ruyter, P.G.1
Kuipers, O.P.2
Vos, W.M.3
-
36
-
-
0036156789
-
Montes de Oca-Luna R, Le Loir Y. Production of human papillomavirus type 16 E7 protein in Lactococcus lactis
-
Bermúdez-Humarán LG, Langella P, Miyoshi A, Gruss A, Guerra RT. Montes de Oca-Luna R, Le Loir Y. Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl Environ Microbiol. 2002;68:917-22.
-
(2002)
Appl Environ Microbiol.
, vol.68
, pp. 917-922
-
-
Bermúdez-Humarán, L.G.1
Langella, P.2
Miyoshi, A.3
Gruss, A.4
Guerra, R.T.5
-
37
-
-
33646556395
-
Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens
-
Hütt P, Shchepetova J, Lõivukene K, Kullisaar T, Mikelsaar M. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J Appl Microbiol. 2006;100:1324-32.
-
(2006)
J Appl Microbiol.
, vol.100
, pp. 1324-1332
-
-
Hütt, P.1
Shchepetova, J.2
Lõivukene, K.3
Kullisaar, T.4
Mikelsaar, M.5
-
38
-
-
0037023582
-
Effect of a BLT receptor antagonist in a model of severe ischemia and reperfusion injury in the rat
-
Souza DG, Pinho V, Cassali GD, Poole S, Teixeira MM. Effect of a BLT receptor antagonist in a model of severe ischemia and reperfusion injury in the rat. Eur J Pharmacol. 2002;440:61-9.
-
(2002)
Eur J Pharmacol.
, vol.440
, pp. 61-69
-
-
Souza, D.G.1
Pinho, V.2
Cassali, G.D.3
Poole, S.4
Teixeira, M.M.5
-
39
-
-
0021890916
-
Production and functional properties of eosinophils from bone marrow cultures
-
Strath M, Sanderson CJ. Production and functional properties of eosinophils from bone marrow cultures. J Cell Sci. 1985;74:207-17.
-
(1985)
J Cell Sci.
, vol.74
, pp. 207-217
-
-
Strath, M.1
Sanderson, C.J.2
-
40
-
-
36448942500
-
Acidification is not involved in the early inhibition of Staphylococcus aureus growth by Lactococcus lactis in milk
-
Charlier C, Even S, Gautier M, Le Loir Y. Acidification is not involved in the early inhibition of Staphylococcus aureus growth by Lactococcus lactis in milk. Int Dairy J. 2008;18:197-203.
-
(2008)
Int Dairy J.
, vol.18
, pp. 197-203
-
-
Charlier, C.1
Even, S.2
Gautier, M.3
Loir, Y.4
-
41
-
-
70349339546
-
Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile
-
Stringer AM, Gibson RJ, Bowen JM, Logan RM, Ashton K, Yeoh AS, Al-Dasooqi N, Keefe DM. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol. 2009;90:489-99.
-
(2009)
Int J Exp Pathol.
, vol.90
, pp. 489-499
-
-
Stringer, A.M.1
Gibson, R.J.2
Bowen, J.M.3
Logan, R.M.4
Ashton, K.5
Yeoh, A.S.6
Al-Dasooqi, N.7
Keefe, D.M.8
-
42
-
-
84919446072
-
Microbiota and their role in the pathogenesis of oral mucositis
-
Vanhoecke B, De Ryck T, Stringer A, Van de Wiele T, Keefe D. Microbiota and their role in the pathogenesis of oral mucositis. Oral Dis. 2015;21:17-30.
-
(2015)
Oral Dis.
, vol.21
, pp. 17-30
-
-
Vanhoecke, B.1
Ryck, T.2
Stringer, A.3
Wiele, T.4
Keefe, D.5
-
43
-
-
33644775719
-
Morselli Labate AM, Pantaleo MA, De Vivo A, Biasco G. Intestinal microflora and digestive toxicity of irinotecan in mice
-
Brandi G, Dabard J, Raibaud P, Di Battista M, Bridonneau C, Pisi AM. Morselli Labate AM, Pantaleo MA, De Vivo A, Biasco G. Intestinal microflora and digestive toxicity of irinotecan in mice. Clin Cancer Res. 2006;12:1299-307.
-
(2006)
Clin Cancer Res.
, vol.12
, pp. 1299-1307
-
-
Brandi, G.1
Dabard, J.2
Raibaud, P.3
Di, B.M.4
Bridonneau, C.5
Pisi, A.M.6
-
44
-
-
84875607679
-
Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors
-
Thorpe DW, Stringer AM, Gibson RJ. Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors. Exp Biol Med. 2013;238:1-6.
-
(2013)
Exp Biol Med.
, vol.238
, pp. 1-6
-
-
Thorpe, D.W.1
Stringer, A.M.2
Gibson, R.J.3
-
45
-
-
84979529833
-
Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice
-
Pedroso SHSP, Vieira AT, Bastos RW, Oliveira JS, Cartelle CT, Arantes RME, Soares PMG, Generoso SV, Cardoso VN, Teixeira MM, et al. Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice. Microbiology. 2015;161:1950-60.
-
(2015)
Microbiology.
, vol.161
, pp. 1950-1960
-
-
Pedroso, S.H.S.P.1
Vieira, A.T.2
Bastos, R.W.3
Oliveira, J.S.4
Cartelle, C.T.5
Arantes, R.M.E.6
Soares, P.M.G.7
Generoso, S.V.8
Cardoso, V.N.9
Teixeira, M.M.10
-
46
-
-
53149083364
-
Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution
-
Soares PMG, Mota JMSC, Gomes AS, Oliveira RB, Assreuy AMS, Brito GAC, Santos AA, Ribeiro RA, Souza MHLP. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol. 2008;63:91-8.
-
(2008)
Cancer Chemother Pharmacol.
, vol.63
, pp. 91-98
-
-
Soares, P.M.G.1
Mota, J.M.S.C.2
Gomes, A.S.3
Oliveira, R.B.4
Assreuy, A.M.S.5
Brito, G.A.C.6
Santos, A.A.7
Ribeiro, R.A.8
Souza, M.H.L.P.9
-
47
-
-
84866428325
-
Adenovirus-mediated hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein suppresses dextran sulfate sodium-induced acute ulcerative colitis in rats
-
Lv Y, Yang X, Huo Y, Tian H, Li S, Yin Y, Hao Z. Adenovirus-mediated hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein suppresses dextran sulfate sodium-induced acute ulcerative colitis in rats. Inflamm Bowel Dis. 2012;18:1950-60.
-
(2012)
Inflamm Bowel Dis.
, vol.18
, pp. 1950-1960
-
-
Lv, Y.1
Yang, X.2
Huo, Y.3
Tian, H.4
Li, S.5
Yin, Y.6
Hao, Z.7
-
48
-
-
84982993861
-
Beneficial effect of Lactococcus lactis NCC 2287 in a murine model of eosinophilic esophagitis
-
Holvoet S, Doucet-Ladevèze R, Perrot M, Barretto C, Nutten S, Blanchard C. Beneficial effect of Lactococcus lactis NCC 2287 in a murine model of eosinophilic esophagitis. Allergy. 2016;71(12):1753-61.
-
(2016)
Allergy.
, vol.71
, Issue.12
, pp. 1753-1761
-
-
Holvoet, S.1
Doucet-Ladevèze, R.2
Perrot, M.3
Barretto, C.4
Nutten, S.5
Blanchard, C.6
-
50
-
-
84904772635
-
Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis
-
Luerce TD, Gomes-Santos AC, Rocha CS, Moreira TG, Cruz DN, Lemos L, Sousa AL, Pereira VB, de Azevedo M, Moraes K. Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis. Gut Pathog. 2014;6:33.
-
(2014)
Gut Pathog.
, vol.6
, pp. 33
-
-
Luerce, T.D.1
Gomes-Santos, A.C.2
Rocha, C.S.3
Moreira, T.G.4
Cruz, D.N.5
Lemos, L.6
Sousa, A.L.7
Pereira, V.B.8
Azevedo, M.9
Moraes, K.10
-
51
-
-
0027140509
-
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
-
Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA. 1993;90:11478-82.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 11478-11482
-
-
Fynan, E.F.1
Webster, R.G.2
Fuller, D.H.3
Haynes, J.R.4
Santoro, J.C.5
Robinson, H.L.6
-
52
-
-
31544455294
-
Acceleration of proteolysis during ripening of Cheddar-type cheese using of a streptokinase-producing strain of Lactococcus
-
Upadhyay VK, Ravn P, Israelsen H, Sousa MJ, Kelly AL, McSweeney PL. Acceleration of proteolysis during ripening of Cheddar-type cheese using of a streptokinase-producing strain of Lactococcus. J Dairy Res. 2006;73:70-3.
-
(2006)
J Dairy Res.
, vol.73
, pp. 70-73
-
-
Upadhyay, V.K.1
Ravn, P.2
Israelsen, H.3
Sousa, M.J.4
Kelly, A.L.5
McSweeney, P.L.6
-
53
-
-
70349422112
-
Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice
-
Nishitani Y, Tanoue T, Yamada K, Ishida T, Yoshida M, Azuma T, Mizuno M. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice. Int Immunopharmacol. 2009;9:1444-51.
-
(2009)
Int Immunopharmacol.
, vol.9
, pp. 1444-1451
-
-
Nishitani, Y.1
Tanoue, T.2
Yamada, K.3
Ishida, T.4
Yoshida, M.5
Azuma, T.6
Mizuno, M.7
-
54
-
-
84934933158
-
Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons
-
Ballal SA, Veiga P, Fenn K, Michaud M, Kim JH, Gallini CA, Glickman JN, Quéré G, Garault P, Béal C, et al. Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons. Proc Natl Acad Sci USA. 2015;112:7803-8.
-
(2015)
Proc Natl Acad Sci USA
, vol.112
, pp. 7803-7808
-
-
Ballal, S.A.1
Veiga, P.2
Fenn, K.3
Michaud, M.4
Kim, J.H.5
Gallini, C.A.6
Glickman, J.N.7
Quéré, G.8
Garault, P.9
Béal, C.10
|